Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs
Bullboard Posts
User Avatar Image
(5)
•••
Comment by roadking08on Jun 14, 2017 9:28pm
100 Views
Post# 26364332

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:biOasis CEO Dr. Mark Day Releases Details of Corporate Plans

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:biOasis CEO Dr. Mark Day Releases Details of Corporate PlansSpeaking of Eve, I saw many drawings of her lately...on all drawings she had a belly button, I'll give you all here a chance to reflect on that.
On a lighter note....not than I'm pulling for observer, but he does have a point or two for an augmentation in points.
Nothing to cross him over the bridge RH did say some things that could be determine by some shareholders or wanna bees been had that in retrospect was an eany weeny meany bit,  tiny little bit  I see bit misleading in some certain announcements, 
june 24 is fast approaching, even down here we will celebrate it...you can try to start fireworks with a hockey stick, but the stick must be first put upside down to light up fireworks to make sure you don't get burned.
And yes I got burned also....no smarter than anyone here, just smart enough to se Eve has a belly button 
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities